INTRODUCTION
The GC (Golgi complex) is a central organelle in the endomembrane system whose origin dates back to the last common eukaryotic ancestor [1] . Despite its ancient origin and the conservation of many of the Golgi-associated proteins, the structure of the GC varies in different organisms. In most the Golgi is arranged as a stack of flattened membrane structures (cisternae) ordered in a polarized (cis-to-trans) fashion. However, whereas in mammalian cells the stacks are laterally linked to form a ribbon-like membrane system [2] , in plants, invertebrates and fungi the Golgi stacks exist as isolated entities [3, 4] . In addition, in some developmental stages of Drosophila melanogaster no stacks are observed [4] , whereas in the yeast Saccharomyces cerevisiae the diverse Golgi cisternae exist as separate compartments distributed throughout the cell [5, 6] . Although this variability raises the question as to whether and how the structure of the GC is correlated with its functions, it also suggests the possibility that the higher complexity of the structure of the GC in vertebrates, and particularly in mammals, is required to accomplish more complex functions that the organelle has gradually gained during evolution.
Indeed, the last two decades have witnessed an explosion in the number of studies that have brought to light an increasing number of functions that converge at the GC and that add to the known and conserved functions of this organelle in biosynthetic and secretory pathways. These 'novel' functions of the GC are so numerous and diverse as to make this organelle an active component of cellular pathways controlling mitotic entry, cytoskeleton organization and dynamics, calcium homoeostasis, and PM (plasma membrane)-receptor-initiated and organelle-autochthonous signalling events that respond to growth signals and energy status. A paradox we are experiencing in the field is that, concomitantly with uncovering so many diverse and unpredicted functions of the GC, we are still left with many open questions about the mechanisms governing the 'classical' trafficking functions of the GC in the secretory pathway.
In the present review we provide a brief overview of the recent developments regarding the 'classical' functions of the GC in transport and processing and discuss in more detail the other functions that contribute to a 'global' understanding of the molecular physiology of the Golgi complex.
A TRANSPORT AND SORTING STATION
The Golgi has a well-established role as a processing and sorting station in the transport of transmembrane and soluble cargo proteins to their final destinations. Various aspects of these processes have been dealt with in detail in recent reviews [7] [8] [9] , so we provide only a brief overview of these Golgi functions.
The GC receives neosynthesized proteins and lipids from the ER (endoplasmic reticulum). Trafficking between the ER and the GC involves the vesicular coat complexes COPII (coatamer protein II), which mediates the concentration of secretory cargoes into anterograde transport carriers, and COPI (coatamer protein I), which recycles material from post-ER membranes back to the ER [7] . Proteins are exported from the ER at specialized exit Abbreviations used: AKAP450, a kinase anchor protein 450 kDa; ATF6, activating transcription factor 6; CDK1, cyclin-dependent kinase 1; CERT, ceramide transport protein; COPI, coatamer protein I; COPII, coatamer protein II; CtBP, C-terminal-binding protein; EGF, epidermal growth factor; ER, endoplasmic reticulum; ERGIC, ER-Golgi intermediate compartment; ERK, extracellular-signal-regulated kinase; FAPP2, four-phosphate adaptor protein 2; GC, Golgi complex; GEF, guanine-nucleotide-exchange factor; GlcCer, glucosylceramide; GM130, Golgi marker 130; GOLPH3, Golgi phosphoprotein 3; GRASP, Golgi reassembly stacking protein; GSL, glycosphingolipid; MAPK, mitogen-activated protein kinase; MEK, MAPK/ERK kinase; MT, microtubule; OSBP1, oxysterol-binding protein 1; PI, phosphoinositide; PI4K, PI 4-kinase; PI4P, PI 4-phosphate; PLK, polo-like kinase; PM, plasma membrane; RasGRP1, Ras guanyl-releasing protein 1; RKTG, Raf kinase trapping to Golgi; SPCA, secretory pathway Ca 2+ -ATPase; SREBP, sterol-regulatory-element-binding protein; SCAP, SREBP-cleavage-activating protein; TGN, trans-Golgi network; TOR, target of rapamycin; TORC1, TOR complex 1; VPS74, vacuolar protein sorting 74; UPR, unfolded protein response. 1 To whom correspondence should be addressed (email dematteis@tigem.it).
sites. In mammalian cells the transport carriers subsequently fuse to form, or fuse with, a network of vesicular tubular clusters also known as the ERGIC (ER-Golgi intermediate compartment)
. The ERGIC appears to be a major sorting centre where many proteins that need to be recycled via COPI-mediated retrograde transport to the ER are separated from cargo that is destined to traverse the GC. The segregated cargo-containing domains may then form the cis-Golgi network or they may fuse with an already existing cis-Golgi. As can be deduced from the above, it is still unclear whether the ERGIC represents a stable compartment or if it is a structure that is continuously formed and consumed by the membrane trafficking between the ER and the Golgi [10, 11] .
Having reached the Golgi the cargo molecules must traverse anything from three to eight cisternae where they are subjected to further processing (mainly glycosylation) that is necessary for either the final functional form of the protein or to direct it to the correct intra-or extra-cellular destination (see below). The mechanism that mediates the transport of cargo through the Golgi has been a matter of debate for years. One view (the vesicular transport model) envisaged each cisterna as a stable entity while the cargo is transported in an anterograde manner via COPI vesicles that bud from one cisterna and then fuse with the next one. However, the finding that COPI has a major role in retrograde transport and that large cargo molecules, in spite of their inability to fit into COPI vesicles, progress through the Golgi cisternae [12] led to a reconsideration and an alternative model for intra-Golgi transport, the cisternal maturation model. In this model, which is presently the most accepted [8] , cargo is maintained within a cisterna that changes its composition (matures) by the retrograde movement of cisternal components (enzymes and lipids) thus achieving the identity of the foregoing cisterna [9] . Strong support for this model came from the visualization of Golgi-resident proteins in living yeast cells, which showed a dynamic transition from cis-to-trans compartmental identity [13] [14] [15] . Despite this, a full description of how cisternal maturation might operate and of the precise role of COPI vesicles is still missing and further clarification is needed to explain the mechanisms underlying Golgi trafficking.
Having traversed the Golgi, the cargo molecules are sorted at the TGN (trans-Golgi network) to various cellular destinations. This is arguably the most complex area of the Golgi, where a multitude of processes are integrated to provide fidelity of processing and sorting. Final modification of glycosylated proteins (see below) and protease cleavage of proteins to their mature form [14] occurs here before their segregation into tubular/vesicular carriers [16] that transport the cargo to the apical or basolateral membranes, or to endosomal/lysosomal compartments. A review [17] has a detailed description of the processing and sorting at the TGN.
Although the GC represents an obligatory station for most secreted proteins, a number of proteins reach the cell surface by by-passing the Golgi in what is known as unconventional trafficking, a process that appears to occur in all organisms [18] . What, if any, type of cross-talk might exist between these pathways provides an interesting area of study for the future. In the present review we have only touched on the remarkable feat of organization that operates at the Golgi in transporting and sorting cargo, details of which can be found in the reviews cited above. However, the GC appears to have a much broader range of functions that regulate cellular homoeostasis, through the control of cellular pathways that mediate protein and lipid biosynthesis, mitotic entry, calcium homoeostasis and PM receptor-initiated/organelle-autochthonous signalling systems, which we describe in more detail below.
A PROTEIN AND LIPID BIOSYNTHETIC CENTRE
Cargo proteins and lipids are subjected to extensive covalent modifications, which are coupled to their transport through and out of the GC [19] . The net result of this activity is to create a number of biological gradients where post-Golgi compartments are enriched in processed compounds while pre-Golgi membranes are enriched in precursors and immature forms.
Proteins and lipids are substrates for N-linked and O-linked glycosylation and oligosaccharide-chain-processing at the GC [19] . N-linked glycosylation starts in the ER, whereas further remodelling occurs following export to the GC. Complex oligosaccharides are generated when the original N-linked oligosaccharide is trimmed in the GC and additional sugars are added. The trimming of mannose residues and the stepwise addition of N-acetylglucosamine, galactose, sialic acid and, in some cases, fucose residues occurs in an organized sequence during protein passage through the GC. The order of enzymatic reactions is mirrored by the sub-Golgi distribution of the processing enzymes [20] with early (i.e. mannose removal and N-acetylglucosamine addition) and late (i.e. galactose, sialic acid and fucose addition) reactions being catalysed by enzymes located in the proximal and distal regions of the GC respectively [21, 22] .
The enzymes responsible for glycosylation in the GC are most frequently type II integral membrane proteins with a C-terminal luminally oriented enzymatic domain, a stem region and a transmembrane domain followed by a short N-terminal cytosolic domain [19] . Although a comprehensive picture of the mechanisms by which different enzymes localize to subdomains of the GC is still missing a number of molecular determinants are known to be involved in controlling the sub-Golgi distribution of the different enzymes, including protein-binding motifs in their cytosolic portion {e.g. to the COPI coatomer or to VPS74 (vacuolar protein sorting 74)/GOLPH3 (Golgi phosphoprotein 3); see below and [19, 23] }, interaction with the COG (conserved oligomeric Golgi) machinery [24] , homo/hetero-oligomerization [25] , partitioning into lipid domains [26, 27] , and transmembrane domain length and composition [26] .
The mechanisms that fine tune the activities of the glycosylating enzymes also remain undefined, although previous findings indicate that the glycosylation process and machinery at the GC play an important role in integrating nutrient-sensing with cell fate determination. A connection between protein glycosylation and the metabolic flux to N-glycan biosynthesis has been established and modelled [28] . Glycan chains are more branched in highnutrient conditions and this has an impact on their interaction with galectins and prolongs the time glycoproteins are exposed at the cell surface by decreasing their endocytosis. In addition, the glycoproteins respond to increasing hexosamine levels according to the number of their N-glycosylation sites. Glycoproteins with many glycosylation sites rapidly increase at the cell surface, whereas those with few sites follow a sigmoidal kinetic preceded by a lag phase. As growth-promoting PM receptors are often rich in glycosylation sites, whereas growth-antagonizing receptors tend to bear less glycosylation sites, the authors of that study [28] speculate that moderate fluxes of nutrients will favour cell growth, whereas further increases will produce a shift towards growth arrest and differentiation.
Furthermore, it has been shown recently that the distribution of O-glycosylation enzymes is sensitive to growth factor stimulation. This stimulation causes a subset of O-glycosylation enzymes to translocate from the GC to the ER (see below and Figure 1 ), thus increasing O-glycosylation levels that may in turn influence cell-cell and cell-ECM (extracellular matrix) interaction [29] .
In spite of the remaining uncertainties, the importance of the glycosylation occurring at the GC is definitively underscored by the severe consequences of human genetic diseases caused by mutations in glycosylating enzymes, as well as in the dedicated trafficking machineries responsible for their intracellular distribution [30] .
Another class of compounds that is glycosylated at the GC are the sphingolipids, which include sphingomyelin and GSLs (glycosphingolipids) [31] . When transported to the GC, ceramide, the common sphingolipid precursor that is synthesized in the ER, can either be processed to sphingomyelin via the addition of a phosphocholine headgroup or be glycosylated to GlcCer (glucosylceramide) on the cytosolic leaflet of the cis-Golgi. Once produced and translocated into the lumen of the GC, GlcCer can be further glycosylated to different classes of complex GSL (such as gangliosides and globosides), depending on the nature of sugars added to the GlcCer backbone [31] .
The sphingolipid metabolic pathway has recently attracted new interest as it has uncovered a novel paradigm of transport to and through the GC. This is the non-vesicular transport of ceramide and GlcCer that is mediated by the lipid transfer proteins CERT (ceramide transport protein) and FAPP2 (four-phosphate adaptor protein 2) respectively [32] [33] [34] . CERT mediates the non-vesicular transport of ceramide from the ER to the late GC, where ceramide is converted into sphingomyelin [32] . The pool of ceramide escaping CERT-mediated transport is inserted into membrane-bound carriers and transported to the cis-Golgi where it is converted into GlcCer. GlcCer is in turn subjected to non-vesicular transport mediated by FAPP2, which fosters complex GSL production on later Golgi compartments [33] . In addition to their lipid transfer activities, both CERT and FAPP2 also participate in secretory cargo transport from the GC to the cell surface [35] [36] [37] . Thus, by coupling sphingolipid processing with transport out of the GC, these proteins contribute to one of the key functions of the GC, namely the generation of asymmetry in lipid distribution in the cell membranes with late and post-GC compartments enriched and pre-and early Golgi compartments depleted in sphingolipids [38] . A similar consideration is also applicable to the two cholesterol transfer proteins OSBP1 (oxysterol-binding protein 1) and ORP9 (oxysterol-binding protein-related protein 9), which are thought to mediate cholesterol transport from the ER directly to the trans-Golgi, and, by so doing, to contribute to the enrichment of cholesterol in post-GC compartments [39] .
AN MT (MICROTUBULE) NUCLEATION CENTRE
The structure and the positioning of the mammalian Golgi ribbon next to the centrosome requires an intact MT and actin cytoskeleton [40] . Treatment of cells with the MT-depolymerizing agent nocodozole causes the breakdown of the GC into functional mini-stacks in the vicinity of ER exit sites [41] . Indeed, the centrosome is the major MT nucleation and anchorage centre in cultured animal cells. Generally, the MTs are organized in radial arrays with their minus ends anchored to the centrosome and the plus ends directed toward the cell periphery. This population of MTs requires γ TuRC (γ tubulin ring complex) complexes and the large scaffold protein AKAP450 (a kinase anchor protein 450 kDa) for their nucleation [42] . MTs that are nucleated at the centrosome form the tracks along which the Golgi stacks are transported to the pericentriolar region through the activity of the minus-end-directed motor dynein, and interfering with its function by overexpressing p50 dynamitin or the CC1 domain of p150
Glued results in dispersed Golgi stacks in the cytosol [43] .
Importantly, the GC not only depends on MT organization but is also able to nucleate two different classes of MTs. A subset of Golgi-nucleated MTs are involved in the cohesion of the stacks into a larger ribbon structure. The other subset extends asymmetrically towards the leading edge of a migrating cell [43] . The ability of Golgi membranes to nucleate MTs requires AKAP450, which in turn is recruited to cis-Golgi membranes by binding to GM130 (Golgi marker 130) [44] . This GM130-dependent Golgi-localized AKAP450 regulates MT nucleation and cell migration in a centrosome-independent manner [44] . These Golgi-nucleated MTs are coated with CLASP [CLIP (cytoplasmic linker protein)-associated proteins], a class of MT plus-end binding protein that promotes the stabilization of dynamic MTs [43] , and are preferentially oriented towards the leading edge in motile cells.
Therefore, as proper organization of MT arrays is essential for intracellular trafficking and cell motility, the Golgi-originated MTs could contribute to the asymmetric MT networks in polarized cells and support diverse processes including post-Golgi transport to the cell front, a function that is essential for directional cell motility and cell polarization.
AN AGONIST-SENSITIVE CALCIUM STORE
Although the ER is the major agonist-sensitive intracellular Ca 2+ store, it is now clear that the GC can also release Ca 2+ during agonist stimulation and can contribute to the duration and pattern of intracellular Ca 2+ signalling [45, 46] . Interestingly, in addition to responding to extracellular stimuli, the GC can also release Ca 2+ in response to the arrival of secretory cargo from the ER, as shown recently by the release of Ca 2+ measured during synchronized waves of transport from the ER to, and through, the GC [47] .
The GC actively captures Ca 2+ reaching a high Ca 2+ content (>10 mmol/l) via two classes of Ca 2+ pumps: the SERCAs (sarcoplasmic/endoplasmic reticulum Ca 2+ -ATPases) and the SPCAs (secretory pathway Ca 2+ -ATPases), which also capture Mn 2+ . The critical role of SPCA1 as a Ca 2+ and Mn 2+ pump is highlighted by the observation that haplo-insufficiency of human SPCA1 results in Hailey-Hailey disease, a skin disorder characterized by keratinocyte cell adhesion defects [48, 49] . Ca 2+ sequestered into the Golgi lumen is buffered by different Ca 2+ -binding proteins, such as CALNUC, Cab45 and P54/NEFA. The release of Ca 2+ from the GC, which involves both IP 3 (inositol trisphosphate)-dependent and -independent channels, may serve different functions. First, Ca 2+ regulates trafficking in different parts of the secretory pathway, such as ER-toGolgi, intra-Golgi and Golgi-to-PM transport, by controlling a series of trafficking machineries, such as COPII, COPI and cPLA 2 (cytoplasmic phospholipase A 2 ). Secondly, changes in luminal Ca 2+ may affect Ca 2+ -dependent luminal processes, such as processing and the sorting pattern of PM proteins (receptors, channels and enzymes). Finally, the Ca 2+ released from the GC may participate in 'local' organelle and interorganelle signalling, in particular with those organelles that have a close spatial relationship with the GC, such as secretory granules and mitochondria.
A SIGNALLING PLATFORM
In addition to the well-documented PM-located signalling pathways, signalling from various endomembrane locations appears to be widespread [50] . The presence of various elements of signal transduction cascades on the GC has been documented for a number of years. The demonstration that truly Golgi-localized signalling events exist has been complicated as they share many of the molecular elements that are involved in classical PM-initiated cascades. However, recent evidence has reenforced the idea that the GC can act as a platform for regulating a variety of cellular functions via signalling (see Figures 1-3) . Such signalling events could be involved in GC function (structure and trafficking) or act as part of a relay system for signals derived from other intra-organellar structures or from the PM. In addition to signals arriving at the GC to initiate a response, the signal transduction cascade could be initiated within the GC itself.
A relay station for PM-initiated signalling
The classical Ras/MAPK (mitogen-activated protein kinase) signalling pathway is triggered at the PM by the activation of various receptors and affects many important cellular functions [51] . However, Ras-mediated signalling has also been described on endomembrane systems including the endosomes, ER and the GC. GTP-bound Ras accumulates on the GC in response to growth factor signalling as shown by the recruitment of a GFP (green fluorescent protein)-Raf-1-RBD (Ras-binding domain) reporter that has a high affinity for activated Ras [52] . Ras activation, indeed, may occur in situ on the GC as a Ras GEF (guanine-nucleotide-exchange factor), RasGRP1 (Ras guanylreleasing protein 1), is recruited to the GC upon EGF (epidermal growth factor) stimulation in a Ca 2+ -dependent fashion [53] (Figure 1) . Activation of Ras at the GC does not require vesicular transport and occurs subsequently to Ras signalling at the PM that is switched off by the Ca 2+ -dependent recruitment of the Ras GAP (GTPase-activating protein) CAPRI (Ca 2+ -promoted Ras inactivator) [53] . Therefore the same second messenger, i.e. Ca 2+ , is co-ordinating the shutdown of one signalling event while activating another at a different cellular location.
Interestingly, the targeting of Raf to different Ras nanoclusters at the PM and at the GC results in differential MAPK outputs [54] : whereas signalling at the PM responds to signal inputs with maximal MAPK output, the Golgi-localized signalling is graded and occurs at a later time than the PM activation. Compartmentalized signalling of Ras at the GC or the PM, depending on the stimulus, in mammalian cells can also determine the physiological outcome [55, 56] . Differential PM and endomembrane signalling via Ras also occurs in the fission yeast Schizosaccharomyces pombe where Ras1p signalling controls two distinct pathways: Ras1p-mediated signalling at the ER controls cell morphology, whereas that at the PM drives mating [57] .
Although there is still some controversy about the in situ activation of Ras at the GC [58] it has been proposed that active Ras at the GC could control the spatio-temporal assembly in this compartment of the active MEK/ERK/SEF complex, [where ERK is extracellular-signal-regulated kinase and SEF is similar expression to FGF (fibroblast growth factor), a MAPK scaffold] in response to mitogen stimulation [59] . Interestingly, the MAPK activity is directed towards the cytosolic substrate RSK2 (ribosomal S6 protein kinase 2), but blocked in its ability to act on the nuclear substrate Elk1 (Ets-like gene 1).
Finally, the GC can also act as a negative regulator of signalling pathways as in the case of RKTG (Raf kinase trapping to Golgi), a seven-transmembrane protein localized at the GC, which sequesters Raf-1 from the cytoplasm, blocks EGFstimulated Raf-1 membrane translocation, reduces the interaction of Raf-1 with Ras and MEK1 and, by inhibiting the ERK signalling pathway, blocks NGF (nerve growth factor)-mediated PC12 cell differentiation [60] (Figure 1) .
These results point to an interesting paradigm where the type, duration and strength of the signal originating at the PM can be transduced into different physiological outcomes that depend on the physiological context and rely on compartmentalized signalling from endomembrane platforms. Although as yet there has been no direct demonstration that oncogenic Ras might function at this level, the above-mentioned effects of Ras targeting to the Golgi or the ER open up this possibility. Indeed, various forms of cancer have been linked to signalling via proteins mistargeted to the Golgi or defects in Golgi-associated proteins (Table 1) .
A node in signalling pathways controlling lipid homoeostasis, ER stress response and nutrient sensing

Lipid homoeostasis
Lipid homoeostasis is intimately associated with intracellular membrane trafficking [61] . Intracellular signalling via the Golgi has been elegantly demonstrated by analysis of the sterolsensing signalling pathway involving SREBPs (sterol-regulatoryelement-binding proteins), transcription factors that target genes involved in lipid synthesis. There are three SREBPs, with SREBP1a and -1c representing alternative transcripts, and with SREBP-2 encoded by a separate gene. SREBP-1c appears to control fatty acid synthesis, whereas SREBP-2 controls cholesterol synthesis [62] . High levels of sterols maintain SREBPs as inactive precursors in the ER where they are bound by SCAP (SREBP-cleavage-activating protein), which interacts with the ER resident INSIG (insulin-induced gene) and blocks interaction with the COPII vesicle coat. When sterols levels are low, SREBP-SCAP is transported to the GC where a two-step proteolytic cleavage releases the mature form of SREBP, which then translocates to the nucleus where it binds to sterol-response Table 1 Oncogenes and the GC Activation of the proto-oncogene Ras on the Golgi can lead to cell transformation [53] . The proto-oncogene Src is activated on the Golgi [87] but to date there has been no demonstration that Src mutations lead to oncogenesis via Golgi signalling. The KIT(D816V)-activating mutation of the receptor tyrosine kinase proto-oncogene c-KIT may be blocked in a constitutively active form on the Golgi and has transforming activity [101] . The GC-associated protein FIG (fused in glioblastoma) , fused with the kinase domain of the proto-oncogene, c-ROS localizes to the Golgi and results in constitutive kinase activation and oncogenic transformation [102] . Amplification of the Golgi protein GOLPH3 is associated with human cancer by enhancing growth-factor-induced mTOR (mammalian TOR) activity [103] . MAPK-mediated constitutive localization of ATF6 to the nucleus is required for the prolonged survival of dormant but not proliferative carcinoma cells [104] . Overexpression of the RKTG protein can sequester oncogenic B-Raf to the Golgi and have a suppressive role in human melanoma by inhibiting Raf-dependent ERK activation, cell proliferation and transformation [105] .
Gene
Defect SREBPs are transported from the ER to the Golgi, proteolytically cleaved by the Site 1 and Site 2 proteases (P1S and P2S) and the mature form translocates to the nucleus (N) to activate transcription. Under glucose-replete conditions (bottom section) TOR activity is required for SREBP-1, but not SREBP-2, activity (where exactly this input occurs is unknown). This SREBP-1 activity is inhibited in low-glucose conditions (top section) while SREBP2 activity is blocked by the binding of the ER-stress transcription factor ATF6. ATF6-dependent transcription is, however, enhanced under low-glucose conditions.
elements in the promoters of multiple target genes [63, 64] including those involved in sterol synthesis (Figure 2 ).
UPR (unfolded protein response)
ATF6 (activating transcription factor 6), a master regulator of the UPR, also requires transport from the ER to the Golgi where it is cleaved by the same proteases that act on SREBPs before translocation to the nucleus, where it activates expression of the ER stress-response genes [65] . Release from the ER and transport to the Golgi requires ATF6 dissociation from the ER chaperone BiP (binding immunoglobulin protein) and interaction with the COPII complex for inclusion into ER-to-Golgi carriers [66] . In the absence of the site 2 protease, ATF6 is retained in the Golgi and transcription of the stress-response genes is blocked [67] .
The ATF6-responsive mechanism may also function in unstressed cells to maintain the correct levels of chaperones and regulate folding for the efficient transport of cargo proteins [67] . Why the above transcription factors have to be transported through the Golgi for activation is presently unclear. One possibility is that this Golgi passage tests and 'signals' that there is a functioning transport system, thus avoiding gene transcription and toxic levels of proteins and lipids that could not be transported to their correct destination. Alternatively, this spatial separation might avoid the inappropriate cleavage of SREBPs during mitosis as they are maintained in separate compartments after Golgi fragmentation [68] .
Nutrient sensing
The control of cell growth and metabolism in response to nutrients and growth factors is operated by TOR (target of rapamycin) [69] , a highly conserved serine/threonine kinase that has also been found to be associated with the ER and the Golgi [70] . Notably, TOR mediates SREBP-1 (but not SREBP-2) translocation to the nucleus in a manner that depends on the presence of glucose [71] . Low glucose levels block SREBP-1 activation and lead to inhibition of nuclear SREBP-2 by ATF6. In fact glucose deprivation may result in an ER stress response where the cleaved ATF6 binds the cleaved SREBP-2 transcription factor thus inhibiting lipogenesis [72] (Figure 2) .
Nutrient limitation in yeast leads to TOR-mediated translocation of the transcription factor Gln3p from the TGN/endosome compartment to the nucleus, a translocation that requires Golgi-to-endosome trafficking [73, 74] . TORC1 (TOR complex 1) in yeast has been localized to the Golgi and endosomal compartments [75, 76] , and mutation of Lst8p, a TORC1 protein, also results in the mislocalization of Gln3p to the nucleus [77] .
A centre for integrating cell growth and trafficking
The GC is an active PI (phosphoinositide)-metabolizing centre [78] . Among the PI-metabolizing enzymes that are particularly relevant for their role at the GC are PI4KIIIβ (phosphoinositide 4-kinase class IIIβ) and its yeast homologue Pik1p that synthesizes PI4P (phosphoinositide 4-phosphate). They control TGN-to-PM transport of newly synthesized cargo and the structure of the GC itself [79] [80] [81] .
Interestingly, the balance between synthesis (by PI4Ks) and removal (by the PI4P phosphatase Sac1p) of PI4P at the GC varies depending on nutrient availability and growth stage. Under nutrient-replete conditions in yeast Sac1p is localized to the ER but upon glucose starvation or in quiescent cells it translocates to the GC where it reduces the levels of PI4P thus inactivating trafficking [82] . Upon glucose re-addition or mitogenic stimulation Sac1p shuttles back to the ER via a COPI-mediated mechanism (Figure 3) . In mammalian cells this relocation of Sac1 to the ER relies on the dissociation of Sac1 oligomers at the TGN and requires the p38 MAPK (Figure 3) . In stationary-phase yeast cells or after glucose depletion this Sac1p shuttling is accompanied by a dissociation of Pik1p and Frq1p (a non-catalytic subunit required for Pik1p localization on the GC), away from the GC to the cytoplasm in a manner that depends on binding to 14-3-3 proteins and that contributes to lower PI4P levels at the GC [83] (Figure 3) .
The levels of PI4P control the recruitment/activation of many proteins that regulate Golgi structure and function. These include the AP1 (adaptor protein 1), the lipid transfer proteins FAPP2, CERT and OSBP1 (reviewed in [78] ) and VPS74/GOLPH3 [84, 85] . In particular VPS74 is required for retrograde trafficking of Golgi enzymes and for their steady-state localization in yeast [23, 84] . In mammals GOLPH3 can bind to MYO18A (myosin XVIIIA) thus linking the Golgi to actin filaments. The resulting tensile force may be required for the formation of the Golgi ribbon and for efficient post-Golgi carrier formation [85] . Finally, GOLPH3 is an oncogene amplified in some human cancers (Table 1) , but exactly how this relates to the interactions described above, including those with PI4P, remains to be clarified.
'Signalling from the inside'
In addition to signalling at the GC in response to extracellular stimuli, or to variations in growth or nutrient conditions, as described above, the GC can also generate 'autochthonous' signalling in response to the arrival of cargo from the ER. It has been well-documented that ER chaperones arriving at the Golgi are recycled to the ER via a KDEL (Lys-Asp-Glu-Leu) receptor/COPI-mediated mechanism [86] . It now appears that this chaperone-KDEL receptor binding is not just for retrieval but has an additional important function in 'activating' the KDEL receptor, which then initiates the activation of a Src family kinase phosphorylation cascade on the GC that in turn activates and is required for intra-Golgi trafficking [87] (Figure 1) . The identification of this novel pathway thus represents a signalling module that is initiated within the Golgi itself to regulate cargo traffic and secretion. One possible function of this cascade is to control Golgi dynamics and cargo exit from the TGN by phosphorylation of the Src substrate dynamin 2 that has a role in membrane fission [88] . Other effectors of the KDEL-receptortriggered signalling cascade at the GC remain to be determined.
Growth factors can also stimulate the retrograde transport of a subset of O-glycosylation enzymes (N-acetylgalactosaminyltransferases) from the Golgi to the ER in a Src-and COPIdependent manner (Figure 1 ) although it is unclear if this depends on the Golgi-localized Src activation [29] .
The Golgi mitotic checkpoint
The mitotic inheritance of the Golgi apparatus in mammalian cells requires the progressive and reversible disassembly of the ribbon into dispersed small fragments. Golgi fragmentation requires the fissioning protein CtBP3 (C-terminal-binding protein 3) [also known as BARS (BFA-dependent ADP-ribosylation substrate)] and the kinases MEK1, Raf1, PLK1 (polo-like kinase 1), PLK3, VRK1 (vaccinia-related kinase 1) and CDK1 (cyclin-dependent kinase 1) [89, 90] . Some of the substrates of these kinases have been identified and include several 'golgins' (i.e. GM130 and golgin 84) and the 'stacking factors' GRASP65 (Golgi reassembly stacking protein 65) and GRASP55, which are a class of Golgilocalized protein forming a complex network that organizes Golgi structure and function [91] .
The first Golgi fragmentation step occurs in the G 2 phase of the cell cycle and consists of the cleavage of the tubular non-compact zones that interconnect the Golgi stacks into a ribbon. This ribbon cleavage produces isolated stacks, which remain structurally and functionally normal, and in their usual pericentriolar position [92, 93] . Importantly, the functional block of the fissioning protein CtBP3, or of the kinase MEK1, causes the inhibition of the ribbon severing and in the arrest of the cell cycle at the G 2 stage [92, 93] . Therefore these studies have revealed that the partitioning of the GC is not passively regulated by cell-cycle transition; instead, it is necessary for entry into mitosis [94] . This cell-cycle block is not mediated by the activation of the well-known DNA damage checkpoint: for this reason, the existence of a novel checkpoint pathway that appears to sense the integrity of the GC, the 'Golgi checkpoint', has been postulated [94] . These findings underscore a regulatory interplay between organelle inheritance and the signalling pathways that regulate cell division.
Once in mitosis, the Golgi stacks undergo further fragmentation, which is independent of CtBP3 and MEK1, and is controlled by CDK1 and PLK1 [90] . Interestingly, the disassembly of the isolated stacks correlates with the release from the Golgi membranes of a set of peripheral proteins that acquire new roles for the completion of cell duplication. For instance, ACBD3 (acyl-CoA-binding-domain-containing 3) is released by Golgi membranes during mitosis and it regulates Numb signalling, and thus represents a mechanism for coupling cell-fate specification and cell-cycle progression [95] . In addition the fraction of clathrin that dissociates from the GC during mitosis is then relocated at the centrosomes, where it anchors the MT fibres and stabilizes the mitotic spindle, a function that is essential for proper chromosome separation [96] . As a final example, when the peripheral Golgi protein Nir2 is phosphorylated by the mitotic kinase Cdk1, it dissociates from the disassembled Golgi and moves to the cleavage furrow and midbody during cytokinesis. The phosphorylated Nir2 acts here as a docking site for Plk1, an essential step for the completion of cytokinesis [97] .
Thus, whereas the severing of the ribbon regulates the entry into mitosis, the disassembly of the stacks can exert a regulatory role on the progression through mitosis. Finally, a recent study has revealed that the mitotic spindle is necessary for the reformation of a Golgi ribbon in daughter cells [98] . Since the Golgi membranes start to reform during cytokinesis [99] , and since Golgi-derived vesicles from both daughter cells not only traffic to the furrow region but dock and fuse there [100] , this could suggest that correct partitioning of Golgi membranes is required for a balanced resumption of membrane trafficking before cell abscission.
CONCLUDING REMARKS
The discovery of so many diverse processes converging at the GC poses the question of whether and how they are controlled by and/or control the 'basic" functions of the GC in membrane trafficking and sorting, and in protein and lipid biosynthesis. Unravelling the interplay among these processes promises to result in a more holistic picture with the expectation of shedding light on the more obscure aspects of the physiology of the GC, an organelle that has been attracting the interest of cell biologists ever since its initial description. 
